Elekta Instrument AB
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible. At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it`s personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Clinical Services
- Market Focus:
- Globally (various continents)
- Year Founded:
- 1972
- Employees:
- Over 1000
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
From vision to reality
We’ve been working openly and proactively with clinicians and our partners for almost half a century to develop sustainable, outcome-driven and cost-efficient solutions that meet evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4700 employees combine passion, science, and imagination to profoundly change cancer care and bring hope to everyone dealing with cancer.
Our Strategy
We want to do our part to move towards a world where everyone has access to the best cancer care. With our strategy ACCESS 2025, we set the focus on closing the access gap, elevating cancer care and increasing the patients’ participation in their own care. One key target is that an additional +300 million people in underserved communities will gain access to radiation therapy around the world.
Board of Directors
The board of directors of Elekta AB is appointed by the annual general meeting of shareholders for a period until the end of the next annual general meeting of shareholders. The board is responsible for the organization of Elekta AB and the management of the Company’s operations in the interest of the Company and all shareholders.
The board of directors comprises eight members. The members of the board are Laurent Leksell, who is also the chairman of the board, Caroline Leksell Cooke, Johan Malmquist, Wolfgang Reim, Jan Secher, Birgitta Stymne Göransson and Cecilia Wikström. There are neither deputy board members nor employee representatives on the board. The general counsel serves as secretary for the board.
The composition of the board meets applicable independence requirements as five of the eight members of the board have been deemed independent in relation to the Company, the executive management and major shareholders. These five members are: Johan Malmquist, Wolfgang Reim, Jan Secher, Birgitta Stymne Göransson and Cecilia Wikström.
The board’s work is regulated by the Swedish Companies Act, the articles of association, the corporate governance code and the working instructions for the board of directors.
The board is responsible for the organization of Elekta AB and the management of the Company’s operations in the interest of the Company and all shareholders. This includes appointing a President and CEO who is responsible for managing the day-to-day operations in accordance with instructions from the board. The responsibilities for the board also include:
- Establishing overall goals and strategy
- Defining guidelines to govern ethical conduct with the purpose of ensuring the long-term ability to create value
- Ensuring an effective system for follow-up and control of the company’s operations and risks that the company and its operations are exposed to
- Ensuring a satisfactory process for monitoring compliance with laws and regulations and other regulatory compliance requirements applicable for the company as well as compliance with internal company regulations
- Ensuring that external information and communications are characterized by openness, and that they are accurate, reliable and relevant
The working instructions for the board of directors establish that the board is to:
- Hold at least seven ordinary meetings per year
- Adopt finance and foreign exchange policies
- Adopt a code of conduct
- Approve a long-term plan and budget, including an investment budget
- Approve investments and similar decisions where the amount of the transaction exceeds SEK 5 M if such a transaction falls outside the approved investment budget
- Decide on acquisition or sale of real property or shares, or acquisition or sale of the assets of, or a major part of the assets of, another company
- Decide on the establishment and liquidation of subsidiaries
- Adopt guidelines for remuneration of senior executives to be approved by the annual general meeting of shareholders
- Decide on terms of employment for the President and CEO according to guidelines for remuneration of senior executives approved by the annual general meeting of shareholders
- Adopt the annual report, year-end report and interim reports
Within the board, there is no special distribution of responsibilities among the members of the board in addition to the duties that the board has delegated to the Compensation and Sustainability Committee and to the audit committee respectively.
Refer to Elekta’s Corporate Governance Report for more information about the Board’s work, meeting attendance and remuneration during the last fiscal year.